- Report
- October 2023
- 190 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- October 2023
- 189 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- October 2023
- 84 Pages
Canada
From €3238EUR$3,500USD£2,723GBP
- Report
- October 2023
- 170 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- October 2023
- 89 Pages
Egypt
From €3238EUR$3,500USD£2,723GBP
- Report
- August 2022
- 140 Pages
Global
From €3932EUR$4,250USD£3,306GBP
- Report
- January 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- October 2021
- 293 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- June 2023
- 111 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- December 2023
- 77 Pages
Global
From €3233EUR$3,495USD£2,719GBP
- Report
- September 2023
- 75 Pages
Global
From €3696EUR$3,995USD£3,108GBP
- Report
- June 2023
- 57 Pages
Global
From €3696EUR$3,995USD£3,108GBP
- Report
- June 2023
- 65 Pages
Global
From €3696EUR$3,995USD£3,108GBP
- Drug Pipelines
- June 2023
- 122 Pages
Global
From €13872EUR$14,995USD£11,666GBP
- Report
- May 2023
- 57 Pages
Global
From €3696EUR$3,995USD£3,108GBP
- Report
- March 2023
- 187 Pages
Global
From €2313EUR$2,500USD£1,945GBP
- Report
- February 2023
- 81 Pages
Global
From €3233EUR$3,495USD£2,719GBP
- Report
- December 2022
- 519 Pages
Global
From €2313EUR$2,500USD£1,945GBP
- Drug Pipelines
- December 2022
- 107 Pages
Global
From €13872EUR$14,995USD£11,666GBP
- Report
- November 2022
- 94 Pages
Global
From €3700EUR$4,000USD£3,112GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more